β-Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors

John T. Mullen; Thomas F. DeLaney; Andrew E. Rosenberg; Long Le; A. John Iafrate; Wendy Kobayashi; Jackie Szymonifka; Beow Y. Yeap; Yen-Lin Chen; David C. Harmon; Edwin Choy; Sam S. Yoon; Kevin A. Raskin; Francis J. Hornicek; Gunnlauger P. Nielsen

Journal ArticleOPEN ACCESS

β-Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors

Mullen J
DeLaney T
Rosenberg A
et al.

The Oncologist (2013) 18(9) 1043-1049

DOI: 10.1634/theoncologist.2012-0449

100Citations

58Readers

Abstract

Describe the frequency of CTNNB1 mutations in sporadic desmoid tumors. Summarize findings regarding CTNNB1 mutation status and disease outcome.

Cite

CITATION STYLE

APA

Mullen, J. T., DeLaney, T. F., Rosenberg, A. E., Le, L., Iafrate, A. J., Kobayashi, W., … Nielsen, G. P. (2013). β-Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors. The Oncologist, 18(9), 1043–1049. https://doi.org/10.1634/theoncologist.2012-0449

β-Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors

Abstract

Cite

Register to see more suggestions